Ontex Group NV ONTEX.BR
Composite 34/100; the shares have moved about 46% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Quality ranks 15/100 — a strong mark against it.
Valuation ranks 83/100 — a strong point in its favour.
Quality ranks 15/100 — a strong mark against it. Growth ranks 16/100 — a strong mark against it. Momentum ranks 17/100 — a strong mark against it.
What the company does Ontex Group NV makes baby, feminine, and adult care products under brands such as Moltex and iD, selling through retailers and healthcare providers across Europe and the US.
Key financials Margins are thin: gross 27.2%, operating 5.2%, net –9.8%. ROE 1.8%, ROA 2.6%, ROCE 10.6%. Revenue fell –6.7% and EPS –68.5% year-over-year. Debt/Equity is 0.68 and net debt/EBITDA 4.16.
Stock health Momentum is weak: –17.70% over 3m, –63.71% over 12m, and 54.70 RSI(14). SIDERAVIA scores Quality 34.3, Growth 10.6, Momentum 10.4, Valuation 88.8.
Price vs fair value The stock trades at a discount of 68.20% versus the 12-month analyst target of 4.02. - Analyst target implies 68.20% upside (analyst count 5.0) - Valuation percentile 88.8/100 suggests deep discount vs peers - H1 2026 earnings call highlighted Focus to Value program (GuruFocus.com) - Net margin –9.8% and EPS –68.5% pressure sentiment - FCF yield 81.4% reflects cash generation despite weak fundamentals
Looking forward Forward P/E 3.69 and EV/EBITDA 4.80 imply extreme valuation, but growth and quality scores remain weak. Execution on the Value program and margin recovery will be key.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.